• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Alveolar hemorrhage associated with platelet glycoprotein IIb/IIIa receptor inhibitors.

作者信息

Ener Rasih Atilla, Bruno Nichole, Dadourian Daniel, Wolf Nelson, Van Decker William, Burke James, Styler Michael, Topolsky David

机构信息

Temple University School of Medicine, Philadelphia, Pennsylvania, USA.

出版信息

J Invasive Cardiol. 2006 Jun;18(6):254-61.

PMID:16751677
Abstract

Platelet glycoprotein IIb/IIIa receptor inhibitors have been shown to improve outcomes in percutaneous coronary interventions. Their use with multiple anticoagulants has been associated with increased bleeding complications. Among these, alveolar hemorrhage is a rare and potentially fatal complication. Six patients with this complication were identified over a four-year period. Patient characteristics, possible risk factors, pathophysiology, prevention and potential treatment options are discussed.

摘要

相似文献

1
Alveolar hemorrhage associated with platelet glycoprotein IIb/IIIa receptor inhibitors.
J Invasive Cardiol. 2006 Jun;18(6):254-61.
2
Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).肝素、糖蛋白IIb/IIIa拮抗剂与冠状动脉介入治疗之间的相互作用。全球急性冠状动脉事件注册研究（GRACE）。
Am Heart J. 2007 Jun;153(6):960-9. doi: 10.1016/j.ahj.2007.03.035.
3
Glycoprotein inhibitors in patients on chronic anticoagulation: safe enough or too much risk?接受长期抗凝治疗患者使用糖蛋白抑制剂：足够安全还是风险过高？
Thromb Haemost. 2010 Jan;103(1):11-2. doi: 10.1160/TH09-10-0694. Epub 2009 Dec 1.
4
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.依诺肝素与普通肝素在非ST段抬高急性冠脉综合征高危患者经皮冠状动脉介入治疗中的疗效和安全性比较：依诺肝素、血运重建和糖蛋白IIb/IIIa抑制剂新策略（SYNERGY）试验
Am Heart J. 2006 Dec;152(6):1042-50. doi: 10.1016/j.ahj.2006.08.002.
5
Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).糖蛋白IIb/IIIa抑制剂与氯吡格雷单独及联合应用于非ST段抬高型心肌梗死的有效性和安全性（来自心肌梗死国家注册研究-4）
Am J Cardiol. 2006 Nov 1;98(9):1125-31. doi: 10.1016/j.amjcard.2006.05.043. Epub 2006 Aug 31.
6
Glycoprotein IIb-IIIa inhibitors in unstable coronary syndromes and percutaneous interventions--a conservative approach.糖蛋白IIb-IIIa抑制剂在不稳定型冠状动脉综合征及经皮介入治疗中的应用——一种保守治疗方法
Rev Port Cardiol. 2003 Jul-Aug;22(7-8):995-1002.
7
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.普拉格雷联合或不联合糖蛋白IIb/IIIa抑制剂在接受经皮介入治疗的急性冠脉综合征患者中的疗效与安全性：TRITON-TIMI 38（通过优化普拉格雷血小板抑制评估治疗转归改善情况-心肌梗死溶栓试验38）分析
J Am Coll Cardiol. 2009 Aug 18;54(8):678-85. doi: 10.1016/j.jacc.2009.05.025.
8
Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.经桡动脉途径在接受急性冠状动脉综合征紧急冠状动脉血管成形术并使用糖蛋白IIb/IIIa抑制剂的患者中减少出血的有效性。
Catheter Cardiovasc Interv. 2009 Sep 1;74(3):408-15. doi: 10.1002/ccd.22008.
9
Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
Catheter Cardiovasc Interv. 2008 Jun 1;71(7):907-8. doi: 10.1002/ccd.21622.
10
Effectiveness of glycoprotein IIb/IIIa inhibitor use during primary coronary angioplasty: results of propensity analysis using the New York State Percutaneous Coronary Intervention Reporting System.
Am J Cardiol. 2007 Feb 15;99(4):482-5. doi: 10.1016/j.amjcard.2006.08.061. Epub 2006 Dec 28.

引用本文的文献

1
A fatal complication of tirofiban in an octogenarian: Diffuse alveolar hemorrhage.替罗非班在一位八旬老人身上引发的致命并发症：弥漫性肺泡出血。
J Cardiol Cases. 2010 Mar 21;2(1):e48-e51. doi: 10.1016/j.jccase.2010.02.002. eCollection 2010 Aug.
2
Diffuse Alveolar Hemorrhage in Patients Undergoing Neurointervention: A Case Report.神经介入治疗患者的弥漫性肺泡出血：一例报告
Anesth Pain Med. 2016 Feb 16;6(5):e33979. doi: 10.5812/aapm.33979. eCollection 2016 Oct.
3
Pulmonary Alveolar Hemorrhage after Clopidogrel Use for ST Elevation Myocardial Infarction.
氯吡格雷致 ST 段抬高型心肌梗死患者发生肺出血
Korean Circ J. 2013 Jul;43(7):497-9. doi: 10.4070/kcj.2013.43.7.497. Epub 2013 Jul 31.
4
Platelets in pulmonary vascular physiology and pathology.肺血管生理学和病理学中的血小板。
Pulm Circ. 2012 Jul;2(3):291-308. doi: 10.4103/2045-8932.101398.
5
Tirofiban-induced diffuse alveolar hemorrhage: after primary angioplasty.替罗非班诱导的弥漫性肺泡出血：在直接经皮冠状动脉腔内血管成形术后
Tex Heart Inst J. 2012;39(1):99-103.